相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
KCNMA1 Expression Is Downregulated in Colorectal Cancer via Epigenetic Mechanisms
Maria Sofia Basile et al.
CANCERS (2019)
IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury
Xin-Xia Feng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
Paolo Fagone et al.
MOLECULAR MEDICINE REPORTS (2019)
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity?
Francesca Gobbin et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF
Ferdinando Nicoletti et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Maria Cristina Petralia et al.
MOLECULES (2019)
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease
Saverio Candido et al.
ONCOLOGY REPORTS (2019)
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression
Maria Cristina Petralia et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis
Salvo Danilo Lombardo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
Eugenio Cavalli et al.
MEDICINA-LITHUANIA (2019)
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
Eugenio Cavalli et al.
BRAIN SCIENCES (2019)
Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling
Salvo Danilo Lombardo et al.
BRAIN SCIENCES (2019)
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mitchell T. Wallin et al.
LANCET NEUROLOGY (2019)
Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients
Murat Kurtuncu et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Differential modulation and prognostic values of immune-escape genes in uveal melanoma
Maria Sofia Basile et al.
PLOS ONE (2019)
Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Salvo Danilo Lombardo et al.
BRAIN SCIENCES (2019)
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis
Katia Mangano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models
Tinghong Ye et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
Santa Mammana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Paolo Fagone et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy
Lijuan Wang et al.
ONCOLOGY LETTERS (2018)
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
Mario Presti et al.
ONCOLOGY LETTERS (2018)
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
Santa Mammana et al.
Oncotarget (2018)
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Katia Mangano et al.
Oncotarget (2018)
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients
Chiara D'Angelo et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Properties of Cytokines in Multiple Sclerosis: Pros and Cons
Kexin Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
Milica Lazarevic et al.
MOLECULES (2018)
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37
Sabrina Giacoppo et al.
FASEB JOURNAL (2017)
MIF and D-DT are potential disease severity modifiers in male MS subjects
Gil Benedek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis
Anastasiya Georgieva Trenova et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
Paolo Fagone et al.
SCIENTIFIC REPORTS (2017)
Multiple sclerosis in the real world: A systematic review of fingolimod as a case study
Tjalf Ziemssen et al.
AUTOIMMUNITY REVIEWS (2017)
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis
Gurdal Orhan et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2016)
Interleukin-37 suppresses ICAM-1 expression in parallel with NF-κB down-regulation following TLR2 activation of human coronary artery endothelial cells
Yandan Xie et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
R. M. Valenzuela et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Dynamic Response Genes in CD4+T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis
Sandra Hellberg et al.
CELL REPORTS (2016)
Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica
Mehrdad Farrokhi et al.
ACTA NEUROLOGICA BELGICA (2015)
Insights into IL-37, the role in autoimmune diseases
Wang-Dong Xu et al.
AUTOIMMUNITY REVIEWS (2015)
IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation
Liang Ye et al.
JOURNAL OF IMMUNOLOGY (2015)
Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
Bingni Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
Claudia A. Nold-Petry et al.
NATURE IMMUNOLOGY (2015)
Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8
Suzhao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immunobiology of IL-37: mechanism of action and clinical perspectives
Shannon Quirk et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Increased Expression of IL-37 in Patients with Graves' Disease and Its Contribution to Suppression of Proinflammatory Cytokines Production in Peripheral Blood Mononuclear Cells
Yanqun Li et al.
PLOS ONE (2014)
Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses
Ana-Maria Bulau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Viviana Annibali et al.
BRAIN (2011)
Gene Expression Changes in Multiple Sclerosis Relapse Suggest Activation of T and Non-T Cells
J. William Lindsey et al.
MOLECULAR MEDICINE (2011)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
Michael Gurevich et al.
BMC MEDICAL GENOMICS (2009)
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy
Irena Dujmovic et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
The MS Co-Operative Research (MS-CORE) group: an alternate approach to fostering multicenter studies
J Cohen et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis
T Kaneko et al.
CYTOKINE (2003)
Increased serum levels of interleukin-18 in patients with multiple sclerosis
F Nicoletti et al.
NEUROLOGY (2001)
Identification and initial characterization of four novel members of the interleukin-1 family
S Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
